Dicot signs development agreements with leading suppliers in formulation
Press release: Uppsala, June 8, 2021. Dicot is preparing for the initial human clinical trials. The way in which the company´s drug candidate is administered to the subjects, so-called formulation, is of the greatest importance for the studies. Therefore, agreements have been signed with two leading companies in formulation development.In parallel with animal studies, several activities are underway within Dicot's work to develop a potency drug with better properties than those of existing drugs. The next major milestone is human clinical trials planned to be launched during 2022. Prior